Sharon Cohen

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 2 papers. Top paper: “The HOPE4MCI study: A randomized double‐blind assessment of AGB101 for the treatment of MCI due to AD”.

The HOPE4MCI study: A randomized double‐blind assessment of AGB101 for the treatment of MCI due to AD

Alzheimer s & Dementia Translational Research & Clinical Interventions(2024)10.1002/trc2.12446

N/A

0.985DataRank · unranked

28 citations

Arnold Bakker, Sharon Rosenzweig‐Lipson, Michael Rosenblum, Russell L. Barton, Marilyn S. Albert +4 more

Clinical Efficacy, Safety and Imaging Effects of Oral Valiltramiprosate in APOEε4/ε4 Homozygotes with Early Alzheimer’s Disease: Results of the Phase III, Randomized, Double-Blind, Placebo-Controlled, 78-Week APOLLOE4 Trial

Drugs(2025)10.1007/s40265-025-02250-5

N/A

0.457DataRank · unranked

20 citations

Aidan Power, David Watson, Anton Porsteinsson, Marwan Sabbagh, Emer MacSweeney +15 more